The 12-HHTrE-LTB4R2 pathway revealed by our study is a mode of SCD-dependent PUFA reprogramming in aHSC which has tumor-promoting paracrine effects likely involving similar reprogramming in tumor cells and other TME cell types. The gene discussed is LTB4R2; the disease is neoplasm.